Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Novel Therapeutics for the Treatment of Nicotine and Alcohol Addiction


Detailed Technology Description

Our scientists have identified a protein-protein coupling between the α7 nicotinic acetylcholine receptor (α7nAChR) and the NR2A subunit of the N‐methyl‐D‐aspartate (NMDA) glutamate receptor as a novel target for treatment of nicotine and alcohol addiction. By characterizing the receptor‐receptor interaction we have developed a peptide that interferes with this coupling leading to the development of a breakthrough therapy capable of delivering enhanced affinity, efficacy, and a superior side effect profile.


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View